BTLA Antikörper
-
- Target Alle BTLA Antikörper anzeigen
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTLA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität (Details)
- Human
- Produktmerkmale
- Affinity purified Rabbit polyclonal CD272 antibody
- Aufreinigung
- CD272 antibody was purified by antigen-affinity chromatography
- Isotyp
- IgG
- Top Product
- Discover our top product BTLA Primärantikörper
-
anti-B and T Lymphocyte Associated (BTLA) antibody
BTLA Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 2E4 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 30-183) antibodyBTLA Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 31-157) antibodyBTLA Reaktivität: Human WB, FACS, ELISA, IHC, ICC, Neut Wirt: Maus Monoclonal 5G1G10 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 179-289) antibodyBTLA Reaktivität: Human WB, FACS, ELISA, IHC, ICC, Neut Wirt: Maus Monoclonal 7H3E3 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 221-289) antibodyBTLA Reaktivität: Human, Maus WB, FACS, ELISA, ICC, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibodyBTLA Reaktivität: Human WB, FACS, IF Wirt: Maus Monoclonal 2G2 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 101-150) antibodyBTLA Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibodyBTLA Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MIH26 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 30-183) antibodyBTLA Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibody (PE)BTLA Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MIH26 PE
-
- Applikationshinweise
- IHC-P: 1:100-1:500, WB: 1:500-1:3000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Supplied as a concentrated soloution containing 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7.0). 0.01 % Thimerosal was added as a preservative.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 deg C for short term storage. Aliquot and store at -20 deg C for long term storage. Avoid repeated freeze/thaw cycles.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Andere Bezeichnung
- CD272 (BTLA Produkte)
- Synonyme
- BTLA antikoerper, BTLA1 antikoerper, CD272 antikoerper, A630002H24 antikoerper, B and T lymphocyte associated antikoerper, BTLA antikoerper, Btla antikoerper
- Pathways
- Cancer Immune Checkpoints
-
